What's breaking now, across thousands of outlets.
Solstice Oncology is advancing a medicine from China’s Harbour BioMed that it believes is able to address the weaknesses of drugs aimed at CTLA-4, a popular but tricky cancer immunotherapy target.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
"Senior citizens today constitute a very large section of our country's population, and the number of senior citizens is increasing very rapidly.
Signs of dementia typically appear in senior dogs, or dogs in the last 25 percent of their lifespan.
Made Fresh Salads Inc. has recalled cream cheese and deli salads after FDA tests found listeria contamination.
Reminiscing about a past romantic partner might seem like a bad idea for your current love life. A new psychology study reveals that experiencing nostalgia for an ex can actually boost satisfaction in…
A new blood-based screening algorithm dramatically reduced the number of unnecessary PET scans needed to recruit patients at risk of Alzheimer's disease for a clinical trial, according to research…
Tyra Biosciences wants to challenge Johnson & Johnson in a low-risk form of bladder cancer. The Phase 2 data it released Wednesday takes a step toward that goal — although you just might have to…
